BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+5.95%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$194M
AUM Growth
+$194M
(+2.4%)
Cap. Flow
+$395K
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
92.1%
Holding
47
New
6
Increased
8
Reduced
4
Closed
7
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$1.67M |
| 2 |
Voyager Therapeutics
VYGR
|
$494K |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$455K |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$373K |
| 5 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$372K |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$2.04M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$857K |
| 3 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
$727K |
| 4 |
ADXS
Advaxis, Inc.
ADXS
|
$231K |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$165K |
Sector Composition
| 1 | Healthcare | 96.21% |
| 2 | Energy | 2.46% |
| 3 | Industrials | 0.44% |
| 4 | Consumer Staples | 0.37% |
| 5 | Consumer Discretionary | 0.07% |
